Common use of Teknika Agreement Clause in Contracts

Teknika Agreement. Gen-Probe is a party to a non-assertion agreement effective February 7, 1997 (the “Teknika Agreement”) with Organon Teknika B.V., having a place of business at Xxxxxxx 00, 0000 XX Xxxxxx, The Netherlands (“Teknika”), which agreement grants certain rights and imposes certain conditions with respect to the transcription-based amplification patent rights set forth in Schedule 8.7. Novartis agrees, at the request of Teknika, to permit and to cooperate fully with an annual review of its manufacturing records (and such other records as may be required) by an impartial, technically qualified third party to verify compliance with the provisions of Section 3.3 of the Teknika Agreement. Selection of such third party shall be subject to the approval of Novartis, such approval to be not unreasonably withheld. The results of such a review as provided to Teknika will consist solely of a finding of compliance or non-compliance. The cost of such review shall be born by Teknika and shall not be unreasonably burdensome for Novartis.

Teknika Agreement. Gen-Probe is a party to a non-assertion agreement effective February 7, 1997 (the “"Teknika Agreement”") with Organon Teknika B.V., having a place of business at Xxxxxxx Bxxxxxx 00, 0000 XX Xxxxxx, The Netherlands (“"Teknika”"), which agreement grants certain rights and imposes certain conditions with respect to the transcription-based amplification patent rights set forth in Schedule 8.7. Novartis C. Chiron agrees, at the request of Teknika, to permit and to cooperate fully with an annual review of its manufacturing records (and such other records as may be required) by an impartial, technically qualified third party to verify compliance with the provisions of Section 3.3 of the Teknika Agreement. Selection of such third party shall be subject to the approval of NovartisChiron, such approval to be not unreasonably withheld. The results of such a review as provided to Teknika will consist solely of a finding of compliance or non-compliance. The cost of such review shall be born by Teknika and shall not be unreasonably burdensome for NovartisChiron.

Teknika Agreement. GenGEN-Probe PROBE is a party to a non-assertion agreement effective February 7, 1997 (the “"Teknika Agreement”") with Organon Teknika B.V., having a place of business at Xxxxxxx Bxxxxxx 00, 0000 XX Xxxxxx, The Netherlands (“"Teknika”"), which agreement grants certain rights and imposes certain conditions with respect to the transcription-based amplification patent rights set forth in Schedule 8.7owned or licensed by GEN-PROBE. Novartis CDS agrees, at the request of Teknika, to permit and to cooperate fully with an annual review of its manufacturing records (and such other records as may be required) by an impartial, technically qualified third party to verify compliance with the provisions of Section 3.3 of the Teknika Agreement. Selection of such third party shall be subject to the approval of NovartisCDS, such approval to be not unreasonably withheld. The results of such a review as provided to Teknika will consist solely of a finding of compliance or non-compliance. The cost of such review shall be born borne by Teknika and shall not be unreasonably burdensome for NovartisCDS.